Semi-Annual Consolidated Statement Of Comprehensive Income

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7252380

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
21,100,000,000 JPY
21,100,000,000 JPY
21,100,000,000 JPY
18,986,000,000 JPY
21,100,000,000 JPY
19,600,000,000 JPY
16,173,000,000 JPY
19,600,000,000 JPY
19,600,000,000 JPY
19,600,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
37,000,000 JPY
84,000,000 JPY
Foreign currency translation adjustment
-378,000,000 JPY
5,691,000,000 JPY
Other comprehensive income
-341,000,000 JPY
5,776,000,000 JPY
Comprehensive income
18,645,000,000 JPY
21,949,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
18,645,000,000 JPY
21,949,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.